President Donald Trump has kept his promise on tariffs — so much so that it’s freaking out investors, economists, CEOs and a growing segment of the population who fear the import taxes will do more harm than good.
Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, according to four sources familiar with the discussions.
Sen. Cory Booker, D-N.J., spoke out against President Donald Trump and Elon Musk on the Senate floor throughout the night after beginning his marathon speech at 7 p.m. Monday.
“I had an emotional affair, but I know I’m a good person,” one woman told The Post. “Even good people do not-so-good things when they’re not in a good place [mentally].”